共 219 条
[1]
Deans KJ(2005)Mechanical ventilation in ARDS: one size does not fit all Crit Care Med 33 1141-1143
[2]
Minneci PC(2006)Drotrecogin alfa (activated): down and not out, but not really in either Crit Care 10 420-1626
[3]
Cui X(2006)When a single pivotal trial should not be enough-the case of drotrecogin-alfa (activated) Intens Care Med 32 604-2428
[4]
Banks SM(2005)Activated protein C: do more survive? Intens Care Med 31 1624-204
[5]
Natanson C(2005)Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial Crit Care Med 33 2426-1030
[6]
Eichacker PQ(2005)Struggle for implementation of new strategies in intensive care medicine: anticoagulation, insulin, and lower tidal volumes J Crit Care 20 199-709
[7]
Friedrich JO(2002)Risks and benefits of activated protein C treatment for severe sepsis N Engl J Med 347 1027-470
[8]
Adhikari NK(2001)Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 699-762
[9]
Meade MO(2001)Recombinant human activated protein C reduced all-cause mortality in patients with severe sepsis ACP J Club 135 81-1037
[10]
Wiedermann CJ(2003)Canadian Association of General Surgeons Evidence Based Reviews in Surgery. 8. Efficacy and safety of recombinant human activated protein C for severe sepsis Can J Surg 46 468-1341